The human gastrointestinal tract is home to trillions of microorganisms known as the gastrointestinal microbiome. Many of the commensal bacteria living in the GI tract play important roles resulting in optimal human health. An imbalance of organisms is associated with disease including Irritable Bowel Syndrome (IBS), Inflammatory Bowel Disease (IBD), as well as extra-intestinal diseases such as metabolic syndrome and autoimmune disease.
Genova's GI Effects® Comprehensive Stool Profile is an advanced stool test that provides immediate, actionable clinical information for the management of gastrointestinal health. Utilizing cutting-edge technologies and biomarkers, including measured commensal bacteria, this test offers valuable insight into digestive function, intestinal inflammation, and the intestinal microbiome.
Dr. Christine Stubbe will navigate through the commensal bacteria measured on the GI Effects Stool Profile and discuss strategies for improving overall balance.
- Learn about the 24 commensal bacteria measured on the GI Effects Stool Profile
- Meet a few key players including Akkermansia muciniphila, Methanobrevibacter smithii, Faecalibacterium prausnitzii, and others
- Recognize patterns commonly seen on the Commensal Balance and Relative Abundance charts, and Firmicutes/Bacteroidetes ratio
- Explore strategies for creating microbiome balance
Christine Stubbe, ND, FABNO
Christine Stubbe, ND, FABNO received her Doctorate of Naturopathic Medicine from Bastyr University in Kenmore, Washington. She completed a 3-year family practice/ oncology residency at Yellowstone Naturopathic Clinic and Frontier Cancer Center in Billings, Montana.
Dr. Stubbe joined the Medical Education team at Genova Diagnostics to provide educational support to practitioners.